about
Correlating coating characteristics with the performance of drug-coated balloons--a comparative in vitro investigation of own established hydrogel- and ionic liquid-based coating matricesRefolding of horseradish peroxidase is enhanced in presence of metal cofactors and ionic liquids.Confined water in imidazolium based ionic liquids: a supramolecular guest@host complex case.Toxicity of ionic liquids: eco(cyto)activity as complicated, but unavoidable parameter for task-specific optimization.Meta-analysis of ionic liquid literature and toxicology.Selected issues related to the toxicity of ionic liquids and deep eutectic solvents--a review.An emerging integration between ionic liquids and nanotechnology: general uses and future prospects in drug delivery.Natural deep eutectic solvents: cytotoxic profile.Environmental Impact of Ionic Liquids: Recent Advances in (Eco)toxicology and (Bio)degradability.Antitumor Activity of Ionic Liquids Based on Ampicillin.The Anticancer Potential of Ionic Liquids.Imidazolium and benzimidazolium-containing compounds: from simple toxic salts to highly bioactive drugs.Virucidal Influence of Ionic Liquids on Phages P100 and MS2.Cytotoxic Activity of Salicylic Acid-Containing Drug Models with Ionic and Covalent Binding.MechanoAPI-ILs: Pharmaceutical Ionic Liquids Obtained through Mechanochemical Synthesis.Enhanced dissolution of ibuprofen using ionic liquids as catanionic hydrotropes.Amphiphilic interactions of ionic liquids with lipid biomembranes: a molecular simulation study.Ionic liquids for addressing unmet needs in healthcare.Choline- versus imidazole-based ionic liquids as functional ingredients in topical delivery systems: cytotoxicity, solubility, and skin permeation studies.Extending pharmacological dose-response curves for salsalate with natural deep eutectic solvents
P2860
Q28543780-C3C3BA73-2EE7-43F1-9E2F-EF1AE326BB18Q30384721-23BF75F9-CFD9-4DBD-8739-437BA7647374Q31110173-109F2587-8C32-423F-BF70-E669E2CBAD26Q34396378-528E78AA-FD24-42E7-8B97-A91D7E83D781Q36680192-065134C5-5198-4E92-84FD-05594351C93FQ38514773-AC39BA38-FF4D-4753-9127-4F50F454FF6EQ38681052-83CD4AFF-1E6B-48D0-AEED-E62B9CBE77F8Q38759433-A35469F0-DA14-4FF4-87D4-47A573DBE355Q38844502-ED7E835C-CB84-4BAC-B1FB-7F3B130B9E7CQ38851417-A8D3AF8E-0C22-4D6C-8954-DB82BFCB5733Q39027001-3DC922EE-D82C-4DE5-8CEF-EA98D1452959Q39065508-38F21147-2120-46FF-9552-980B1C142E91Q40052017-BAC48521-515E-44EF-8A21-AB30CB08B4EFQ41897429-DB86C97B-4118-4C6F-B334-ACEC4A0C6421Q48233703-FDA3FF85-C7BD-4A29-8ED2-7CA7FC51D37CQ50182649-229D7F3A-1AB8-432C-BC04-1A0C91D64027Q52653866-57E7BB59-5BF4-4A1B-9AEC-68753FC14F6AQ52703982-9016736C-C828-4839-BC2C-4BC8E4A14588Q54668761-650FF296-40BD-407F-ACFC-8BCFE6D2E1B3Q57057807-27649BCD-EC6E-4D89-890C-6D64E6230F93
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ionic liquids as active pharmaceutical ingredients.
@en
Ionic liquids as active pharmaceutical ingredients.
@nl
type
label
Ionic liquids as active pharmaceutical ingredients.
@en
Ionic liquids as active pharmaceutical ingredients.
@nl
prefLabel
Ionic liquids as active pharmaceutical ingredients.
@en
Ionic liquids as active pharmaceutical ingredients.
@nl
P2860
P50
P356
P1433
P1476
Ionic liquids as active pharmaceutical ingredients.
@en
P2093
Zeljko Petrovski
P2860
P304
P356
10.1002/CMDC.201100082
P577
2011-05-09T00:00:00Z